Who owns BIODESIX INC COM?
- Ticker: BDSX
- CUSIP Number: 09075x207
Tip: Access positions for across all investors
Analyze quarterly positions in Biodesix with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biodesix stock
Who bought or sold BIODESIX INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AIGH Capital Management | 758k | $11M | 100% | Mar 2026 |
|
| Telemark Asset Management | 490k | $7.1M | 49% | Mar 2026 |
|
| Standard Life Aberdeen | 458k | $6.6M | 75% | Mar 2026 |
|
| Soleus Capital Management | 417k | $6.0M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 255k | $3.7M | 100% | Mar 2026 |
|
| Opaleye Management | 238k | $3.5M | 100% | Mar 2026 |
|
| Vanguard Group | 192k | $1.3M | 6% | Dec 2025 |
|
| Essex Investment Management | 132k | $1.9M | 100% | Mar 2026 |
|
| Stempoint Capital | 70k | $1.0M | 100% | Mar 2026 |
|
| Trexquant Investment | 70k | $1.0M | 153% | Mar 2026 |
|
| Geode Capital Management | 50k | $726k | 18% | Mar 2026 |
|
| Two Sigma Investments | 45k | $656k | 100% | Mar 2026 |
|
| Perkins Capital Management | 45k | $649k | 0% | Mar 2026 |
|
| Sei Investments | 43k | $624k | 100% | Mar 2026 |
|
| Legato Capital Management | 41k | $597k | 100% | Mar 2026 |
|
| GSA Capital Partners | 39k | $571k | -39% | Mar 2026 |
|
| UBS Group | 37k | $534k | 100% | Mar 2026 |
|
| Morgan Stanley | 32k | $470k | 53002% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 29k | $416k | 100% | Mar 2026 |
|
| William Blair $ Company | 28k | $400k | 100% | Mar 2026 |
|
| Jane Street | 27k | $392k | 100% | Mar 2026 |
|
| BlackRock | 25k | $355k | 0% | Mar 2026 |
|
| Millennium Management | 24k | $348k | 100% | Mar 2026 |
|
| State Street Corporation | 18k | $121k | 16% | Dec 2025 |
|
| Hrt Financial | 15k | $223k | 100% | Mar 2026 |
|
| Susquehanna International | 13k | $85k | -22% | Dec 2025 |
|
| Cetera Investment Advisers | 12k | $174k | 20% | Mar 2026 |
|
| Thompson Davis & Co | 12k | $170k | 100% | Mar 2026 |
|
| Northern Trust | 11k | $76k | 100% | Dec 2025 |
|
| Walleye Trading Advisors | 11k | $157k | 100% | Mar 2026 |
|
| Hanson McClain Advisors | 5.0k | $34k | 0% | Dec 2025 |
|
| Vanguard Global Advisers | 1.1k | $15k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 924.00 | $13k | 100% | Mar 2026 |
|
| Tower Research Capital | 193.00 | $1.3k | -70% | Dec 2025 |
|
| Fortitude Family Office | 171.00 | $2.5k | 0% | Mar 2026 |
|
| Group One Trading | 100.00 | $1.5k | 0% | Mar 2026 |
|
| Gill Capital Partners | 13.00 | $189.000500 | 100% | Mar 2026 |
|
| FMR | 1.00 | $7.000000 | 0% | Dec 2025 |
|
| Western Wealth Management | 1.00 | $15.000000 | 100% | Mar 2026 |
|
Who sold out of Biodesix?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Monashee Investment Management | Dec 2025 | 112k | $764k |
| Perceptive Advisors | Dec 2025 | 109k | $739k |
| Silverarc Capital Management | Sep 2025 | 50k | $375k |
| Balyasny Asset Management | Dec 2025 | 33k | $225k |
| Citadel Advisors | Dec 2025 | 26k | $177k |
| None | Dec 2025 | 16k | $110k |
| DRW Holdings | Dec 2025 | 15k | $105k |
| Oracle Investment Management | Sep 2025 | 15k | $113k |
| Royal Bank of Canada | Sep 2025 | 8.9k | $67k |
| Atlantic Trust | Sep 2025 | 1.5k | $11k |
| Barclays | Sep 2025 | 1.00 | $8.000000 |